Text Size
2 studies found for:    15998902 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: sunitinib and rapamycin (Drug will be held)
2 Recruiting Erlotinib and Temsirolimus for Solid Tumors
Condition: Solid Tumors
Intervention: Drug: erlotinib and temsirolimus
To Top

† Indicates status has not been verified in more than two years